Evidence map›Paper›PMID 37895828›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Polyalthic Acid from

Mariana B Santiago, Vinicius Cristian O Dos Santos, Samuel C Teixeira, Nagela B S Silva, Pollyanna F de Oliveira, Saulo D Ozelin, Ricardo A Furtado, Denise C Tavares, Sergio Ricardo Ambrósio, Rodrigo Cassio S Veneziani and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. BthTX-II, an Asp49 PLAPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Diterpenes: Nature's Hidden Gems of Immunomodulation.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mariana B SantiagoLaboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil.ORCID 0000-0002-6060-379X
Vinicius Cristian O Dos SantosLaboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil.
Samuel C TeixeiraLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil.ORCID 0000-0002-1978-1658
Nagela B S SilvaLaboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil.
Pollyanna F de OliveiraNucleus of Research in Sciences and Technology, University of Franca, Franca 14404600, SP, Brazil.
Saulo D OzelinNucleus of Research in Sciences and Technology, University of Franca, Franca 14404600, SP, Brazil.
Ricardo A FurtadoNucleus of Research in Sciences and Technology, University of Franca, Franca 14404600, SP, Brazil.
Denise C TavaresNucleus of Research in Sciences and Technology, University of Franca, Franca 14404600, SP, Brazil.ORCID 0000-0003-4646-5914
Sergio Ricardo AmbrósioNucleus of Research in Sciences and Technology, University of Franca, Franca 14404600, SP, Brazil.
Rodrigo Cassio S VenezianiNucleus of Research in Sciences and Technology, University of Franca, Franca 14404600, SP, Brazil.
Eloisa Amália V FerroLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil.ORCID 0000-0002-7447-2583
Jairo K BastosFaculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040900, SP, Brazil.
Carlos Henrique G MartinsLaboratory of Antimicrobial Testing, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil.ORCID 0000-0001-8634-6878

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior Finance Code 001National Council for Scientific and Technological Development 310632/2013-7; 307387/2016-0São Paulo Research Foundation 2011/13630-7; 2016/23012-2; 2016/20589-7
6 · The paper itself

Abstract

This study aimed at evaluating the potential of

Indexed as

antibacterialantibiofilmantiparasiticCopaifera lucensent-polyalthic acidtoxicity

Identifiers

PMID37895828
PMCPMC10610108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.